{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:25:06Z","timestamp":1793823906351,"version":"4.6.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2011,5,17]]},"DOI":"10.1212\/wnl.0b013e31821a446b","type":"journal-article","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T16:45:18Z","timestamp":1305564318000},"page":"1697-1704","source":"Crossref","is-referenced-by-count":166,"title":["Clinical outcomes of natalizumab-associated progressive  multifocal leukoencephalopathy"],"prefix":"10.1212","volume":"76","author":[{"given":"P.","family":"Vermersch","sequence":"first","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kappos","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gold","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Foley","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Olsson","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cadavid","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bozic","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Richman","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (P.V.), University of Lille Nord de France, Lille, France; Departments of Neurology and Research (L.K.), University Hospital, Basel, Switzerland; St. Josef-Hospital (R.G.), Ruhr University, Bochum, Germany; Rocky Mountain Multiple Sclerosis Clinic (J.F.F.), Salt Lake City, UT; Center for Molecular Medicine (T.O.), Karolinska Hospital, Stockholm, Sweden; and Biogen Idec, Inc. (D.C., C.B., S.R.), Weston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051847"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051586"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054693"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70028-4"},{"key":"e_1_3_7_7_2","first-page":"196","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky DA","year":"1949","unstructured":"Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: , MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949:196.","journal-title":"Evaluation of Chemotherapeutic Agents"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/46.4.M139"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.2.320"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO;2-X"},{"key":"e_1_3_7_11_2","first-page":"384","article-title":"Evaluating cancer patients for rehabilitation potential","volume":"155","author":"O'Toole DM","year":"1991","unstructured":"O'Toole DM, Golden AM. Evaluating cancer patients for rehabilitation potential. West J Med 1991;155:384\u2013387.","journal-title":"West J Med"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.3.187"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01614-08"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1103492"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1179\/016164109X12445505689689"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810316"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810257"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.157"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245850000600601"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00147-004-0779-3"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00800.x"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200406000-00019"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/595299"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280390195315"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00016"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000341766.59028.9d"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70078-9"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/374048"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.179002"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.20.6.828"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e31821a446b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T10:09:15Z","timestamp":1711620555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e31821a446b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":29,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2011,5,17]]}},"alternative-id":["10.1212\/WNL.0b013e31821a446b"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e31821a446b","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.723555467.793511828","asserted-by":"object"}]},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,17]]}}}